Mode
Text Size
Log in / Sign up

Genetic analysis and surgery in P450 oxidoreductase deficiency reveal high rates of skeletal and hormonal abnormalitiesTiny Baby, Big Bones: New Clues for a Rare Disorder

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note high prevalence of skeletal and hormonal abnormalities in PORD requiring multidisciplinary management.

This study combines a systematic review and meta-analysis with a single case report to characterize P450 oxidoreductase deficiency (PORD). The review included 167 patients from 50 studies, while the case report detailed a 7-month-old infant with a novel POR mutation. The primary focus was on clinical findings, allele frequencies, and surgical outcomes, rather than a specific therapeutic intervention for the broader cohort.

Clinical analysis of the 167 patients revealed significant phenotypic prevalence. Skeletal deformities were observed in 124 cases (74.25%), and gonadal deformities in 121 cases (72.46%). Hormonal abnormalities or delayed puberty affected 127 patients (76.05%), and adrenal insufficiency or crisis was noted in 108 patients (64.67%). Among female patients, ovarian cysts were observed in 36 individuals (40.00%).

Genetic analysis identified specific allele frequencies for known variants. The p.R457H variant was found in 27.25% of all PORD patients, whereas the p.A287P variant was present in 14.97%. In the Chinese patient subset, the p.R457H variant frequency was higher at 38.64%. The case report described a novel p.G146fs*111 mutation associated with frontal bossing, craniosynostosis, flat nasal bridge, proximal radioulnar synostosis, clitoromegaly, partial labial fusion, and steroid hormone abnormalities.

In the case report, surgical intervention involving bilateral mandibular distraction osteogenesis and cranial reconstruction alleviated airway obstruction, swallowing difficulty, and craniosynostosis. Safety and tolerability data were not reported for the systematic review cohort, and adverse events were not documented. Key limitations include the observational nature of the data, lack of p-values or confidence intervals, and absence of long-term follow-up. Practice relevance emphasizes that management requires multidisciplinary collaboration, including individualized steroid replacement.

Imagine a baby born with a face that looks different and bones that grow in strange ways. For parents, this is a confusing and scary start to life.

But there is a reason behind these changes. A new study explains a very rare genetic puzzle called Cytochrome P450 oxidoreductase deficiency.

The Hidden Puzzle

This condition happens when a specific gene, called POR, does not work right. Think of this gene like a factory worker who is supposed to help build hormones. When it fails, the body cannot make enough steroid hormones.

Without these hormones, the body goes into overdrive. It tries to fix the problem by making too much of other chemicals. This causes bones to grow too fast or in the wrong shape. It also affects the genitals and adrenal glands.

Doctors often miss this because the symptoms look like many other diseases. A baby might have a flat nose, a large forehead, or fused bones in the arms. Girls might have enlarged clitorises. Boys might have undescended testicles.

What Changed Today

For years, doctors treated the symptoms one by one. They fixed the bones with surgery and gave hormone medicine. But they did not always know the root cause.

This new research changes that. It combines a real-life case with a review of 50 other studies. The team found a specific genetic error that is common in East Asian families.

How the Body Gets Stuck

To understand this, imagine a traffic light that never turns green. Cars (hormones) get stuck at the intersection. They cannot move forward.

In the body, the POR gene acts like the traffic light controller. When it breaks, the traffic jam causes chaos. Bones grow too much. Hormones get mixed up. The adrenal glands stop working properly.

The study found a specific error, called p.G146fs*111, in a baby from Shenzhen. This was a new type of error never seen before. Another common error, p.R457H, shows up in many patients in China.

The Study in Plain English

Researchers looked at one baby and then searched the world for similar cases. They found 167 patients in total from 50 different studies.

Most of these patients had bone problems. About three out of four had skeletal issues. More than seven out of ten had problems with their reproductive organs. Over three out of four had hormone delays or adrenal crises.

The baby in the study had surgery to open up his skull and jaw. This helped him breathe and swallow better. He also started taking special hormone medicine.

But There Is a Catch

This is where things get interesting. Just because we found the gene does not mean we have a cure.

This doesn't mean this treatment is available yet.

The study is still in the research phase. We need to test new medicines to fix the gene itself. For now, the best we can do is manage the symptoms carefully.

What This Means for Families

If your child has strange bone growth or hormone issues, ask about this rare condition. It is important to check the POR gene.

Doctors need to work together. One specialist fixes the bones. Another manages the hormones. Another watches blood pressure. This teamwork keeps patients safe.

The Limitations

This study has limits. It focused on one baby and a group of patients mostly from China. We do not know if this gene error happens in other parts of the world.

Also, the new medicine to fix the gene is not ready. We are still learning how to stop the genetic error from happening.

Scientists will keep looking for more patients. They want to find every version of the broken gene.

Next steps include testing new drugs that can bypass the broken gene. We also need to teach doctors to recognize the signs earlier.

Early detection saves lives. If we catch the problem fast, we can prevent severe bone issues and hormone crises.

This research gives hope to families who have waited too long for answers. It shows that even the rarest diseases deserve attention.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BackgroundCytochrome P450 oxidoreductase deficiency (PORD) is an ultra-rare autosomal recessive disorder caused by mutations in the POR gene and characterized by highly heterogeneous skeletal, genital, and endocrine manifestations. Owing to this complexity, PORD remains frequently underrecognized in clinical practice, and integrated clinical–genetic syntheses remain limited.MethodsA retrospective analysis was conducted on the clinical data of a PORD patient treated at Shenzhen Children’s Hospital. Relevant literature was retrieved from PubMed, Web of Science, and China National Knowledge Infrastructure (CNKI). Reported cases were analyzed with respect to sex, age, geographic distribution, clinical manifestations, and POR gene variants.ResultsThe patient from our hospital, a 7-month-old infant, presented with characteristic features including frontal bossing, craniosynostosis, flat nasal bridge, proximal radioulnar synostosis, clitoromegaly, partial labial fusion, and steroid hormone abnormalities. Genetic testing identified compound heterozygous variants, p.G146fs*111, a novel mutation, and p.R457H. The patient underwent bilateral mandibular distraction osteogenesis and cranial reconstruction, which alleviated airway obstruction, swallowing difficulty, and craniosynostosis. A total of 50 eligible studies were identified, comprising 167 patients (male:female = 77:90). The major clinical findings were skeletal deformities in 124 cases (74.25%), gonadal deformities in 121 (72.46%), hormonal abnormalities or delayed puberty in 127 (76.05%), and adrenal insufficiency or crisis in 108 (64.67%). Additionally, ovarian cysts were observed in 36 female patients (40.00%). Among all patients, the allele frequency of the p.R457H variant was 27.25%, while that of the p.A287P variant was 14.97%. In the 22 Chinese patients, the allele frequency of the p.R457H variant reached 38.64%.ConclusionWe report the clinical features of a PORD patient carrying a novel POR mutation, p.G146fs*111. PORD typically presents with skeletal and genital malformations as well as adrenal insufficiency. Management requires multidisciplinary collaboration, including individualized steroid replacement, regular blood pressure monitoring, and surgical intervention when necessary. The p.R457H variant may represent a hotspot mutation in East Asian populations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.